Xiao Ting-Ting, Li Xian, Feng Jia-Li, Li Yong
Department of Oral and Maxillofacial Surgery, Stomatological Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
Chongqing Key Laboratory of Oral Disease and Biomedical Sciences, Chongqing, People's Republic of China.
Biotechnol Lett. 2018 Mar;40(3):551-559. doi: 10.1007/s10529-018-2508-5. Epub 2018 Jan 18.
We evaluated the potential effects of aspirin combined with vitamin D3 on cell proliferation and apoptosis in oral cancer cells.
Compared to the untreated control or individual drug, the combinations of aspirin and vitamin D3 significantly decreased the rates of cell proliferation by CCK-8 assay, and caused higher rates of cell apoptosis in both CAL-27 and SCC-15 cells by Annexin V-FITC apoptosis assay and flow cytometry. Remarkably, the combined treatment with aspirin and vitamin D3 significantly suppressed the expression of Bcl-2 protein and p-Erk1/2 protein, examined by western blot analysis.
Our study demonstrates that aspirin and vitamin D3 have biological activity against two human OSCC cell lines and their activity is synergistic or additive when two drugs used in combination with therapeutic concentrations. The combination of aspirin and vitamin D3 may be an effective approach for inducing cell death in OSCC.
我们评估了阿司匹林联合维生素D3对口腔癌细胞增殖和凋亡的潜在影响。
与未处理的对照组或单一药物相比,通过CCK-8法检测,阿司匹林和维生素D3的联合用药显著降低了细胞增殖率,并且通过Annexin V-FITC凋亡检测法和流式细胞术检测发现,在CAL-27和SCC-15细胞中,联合用药导致了更高的细胞凋亡率。值得注意的是,通过蛋白质免疫印迹分析检测发现,阿司匹林和维生素D3联合治疗显著抑制了Bcl-2蛋白和p-Erk1/2蛋白的表达。
我们的研究表明,阿司匹林和维生素D3对两种人口腔鳞状细胞癌细胞系具有生物学活性,当两种药物以治疗浓度联合使用时,它们的活性是协同或相加的。阿司匹林和维生素D3的联合使用可能是诱导口腔鳞状细胞癌细胞死亡的有效方法。